Pharmacia's diagnostics climb 33% in first quarter of 1995:
This article was originally published in Clinica
Executive Summary
Swedish-based pharmaceuticals manufacturer Pharmacia saw its allergy diagnostics business climb 33% to SKr 447 million ($62 million) in the 1995 first quarter. It attributes this to a positive trend in most markets - especially in Japan - where a high pollen count boosted demand. Consequently, Pharmacia's market shares have increased. Total first-quarter sales were SKr 6,436 million, down 5% on 1994, but when adjusted for divested operations, revenues were flat. Net income of SKr 825 million was up from SKr 782 million a year earlier.